DailyDoctor Archive Specialties Get app
All orthopaedics briefings

The edition · Orthopaedics

Acetabular osteotomy was linked to longer hip survival in true dysplasia, but not in borderline hips

Twenty-year data on more than a thousand hips separate dysplasia that needs reorientation from borderline hips that mostly do well untreated. Plus how cement choice and mixing order change vancomycin release from spacers, the readiness of AI after hip fracture, and a small Boswellia trial in knee osteoarthritis.

The edition in brief

A Japanese series of 683 hips treated with transposition osteotomy of the acetabulum and 353 untreated contralateral hips found that true dysplasia (lateral centre-edge angle under 20°) left untreated had 69% 20-year survival without advanced arthritis or replacement, against 88% after osteotomy. Borderline hips (20° to under 25°) did well untreated (96%), and osteotomy did not significantly improve failure-free survival there, though arthritis progressed less. It is retrospective. An in vitro study of 60 cement discs loaded with 4 g vancomycin found brand, viscosity and whether monomer or powder went in first changed 28-day elution by up to 120%. A systematic review of 40 studies found machine-learning models after hip fracture predicted mortality moderately to well but were rarely validated externally. A 60-patient trial of a Boswellia extract in mild to moderate knee osteoarthritis reported better WOMAC scores than placebo at eight weeks; it is small and short.

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for orthopaedics, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free